Idiopátiás tüdőfibrózis: vizsgálatok itt: Hollandia
16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 16.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in HollandiaStudy to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
- Where
- Heerlen, Nieuwegein
- Életkor
- 40 év and over
- People
- 324 worldwide
- Run by
- Contineum Therapeutics
See details and how to joinNCT07284459 · EU 2025-521901-42-00 - 2. fázisTaking peopleA Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
- Where
- Amsterdam, Heerlen, Nieuwegein
- Életkor
- 18 év and over
- People
- 139 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-525016-41-00 - 2. fázisTaking peopleAn Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- Where
- Nieuwegein, Rotterdam
- Életkor
- 18 év and over
- People
- 340 worldwide
- Run by
- Avalyn Pharma Inc.
See details and how to joinNCT06951217 - 2. fázisNot yet taking people in HollandiaA Phase 2 trial of AGMB-447 in participants with idiopathic pulmonary fibrosis
- Where
- Heerlen, Nieuwegein
- Életkor
- 18 év and over
- People
- 112 worldwide
- Run by
- Agomab Spain S.L.U.
See details and how to join2026-526404-71-00 - 3. fázisNot yet taking people in HollandiaLong-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
- Where
- Amsterdam, Heerlen, Leiden, Nieuwegein, Rotterdam
- Életkor
- 18 év and over
- People
- 2380 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00 - 2. fázisTaking peopleA Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Where
- Amsterdam, Heerlen, Nieuwegein
- Életkor
- 40 év and over
- People
- 359 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07652658 - 3. fázisNot yet taking people in HollandiaTrial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Where
- Heerlen, Nieuwegein, Nijmegen
- Életkor
- 40 év and over
- People
- 1100 worldwide
- Run by
- PureTech
See details and how to joinNCT07284602 · EU 2025-524493-42-00 - 3. fázisCsak meghívásosExtension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
- Where
- Heerlen, Rotterdam
- Életkor
- 40 év and over
- People
- 1850 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT04905693 - 2. fázisNot yet taking people in HollandiaA Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
- Where
- Heerlen, Rotterdam, Zutphen
- Életkor
- 40 év and over
- People
- 240 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07516951 · EU 2024-514246-37-00 - 2. fázisTaking peopleAn Open-Label Extension Study of Subjects who Received an Avalyn Inhaled Antifibrotic Agent
- Where
- Nieuwegein, Rotterdam
- Életkor
- 18 év and over
- People
- 128 worldwide
- Run by
- Avalyn Pharma Inc.
See details and how to join2024-518289-28-00 - 3. fázisFut, nem toborozA Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis
- Where
- Amsterdam, Heerlen, Nieuwegein, Rotterdam
- Életkor
- 18 év and over
- People
- 239 worldwide
- Run by
- Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503697-21-01 - 3. fázisFut, nem toborozA Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis
- Where
- Heerlen, Leiden, Nieuwegein, Rotterdam
- Életkor
- 18 év and over
- People
- 249 worldwide
- Run by
- Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503699-25-00 - 1. fázisNot yet taking people in HollandiaTargeting fibrotic tissue with a radioactive-labelled Fibrobody, visible using a full-body PET/CT scan (FibroVision)
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 57
- Run by
- Amsterdam UMC Stichting
See details and how to join2025-521143-20-00 - No phaseTaking peoplePRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
- Where
- Rotterdam
- Életkor
- 18 év to 80 év
- People
- 500 worldwide
- Run by
- University of Massachusetts, Worcester
See details and how to joinNCT06855329 - 2. fázisTaking peopleFibroblast markers to tackle fibrosis in immune-mediated inflammatory diseases
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 60
- Run by
- Amsterdam UMC Stichting
See details and how to join2025-522834-30-01 - No phaseTaking peopleP4O2 ILD Extension
- Where
- Amsterdam
- Életkor
- 18 év to 80 év
- People
- 450
- Run by
- Amsterdam UMC, location VUmc
See details and how to joinNCT06644144